Jay Blankenship M.D. Joins Zylö as Vice President of Business Development

02Sep

Jay Blankenship M.D. Joins Zylö as Vice President of Business Development

Portfolio News
Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced Jay Blankenship M.D. has joined its executive team as vice president of business development. Read more >>

Share this post

Related Posts

27Jan

What Gentex’s Acquisition Of eSight Means For The Low-Vision Eyewear Market

Earlier this month, ahead of the start of the annual world-famous Consumer Electronics show held in Las Vegas, Gentex corporation... read more
25Jun

The 10 Hottest Tech Startups Of 2020 (So Far)

Wasabi, a provider of hot cloud storage for businesses, in May unveiled a new $30 million round of funding. The... read more
07Jan

Ottobock Signs Distribution Agreement With Myomo

Ottobock, a market leader in technical orthopedics, and Myomo, Inc., a manufacturer of myoelectric orthotics, have reached an agreement for... read more
16May

Legally blind Poplar Grove siblings surprised with special glasses

"Jack and Colleen's eSight classes have been fully funded," said Manchester Elementary Principal Molly Lilja in a surprise announcement. Through... read more
16Mar

Emovi, Inc. Announces Clinical Collaboration With The Geneva Foundation to Support US Army Soldiers and Veterans Faced With Knee Problems

Emovi, Inc., a leading medical device developer and manufacturer for orthopaedics, announced today a clinical collaboration with the US Army... read more
19Feb

KnipBio aquafeed component granted safe status by US agency

KnipBio announced Monday that it has received generally recognized as safe (GRAS) status for its aquafeed ingredient for salmon and... read more
20May

Aramco Venture Arm Investing in U.S. Startup Wasabi

The venture capital arm of Saudi Arabia’s state-owned energy producer Aramco is investing in Boston-area cloud-storage startup Wasabi Technologies. One... read more
30Dec

Groton Connecticut based Astrocyte Pharmaceuticals is raising $8,655,148.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Astrocyte Pharmaceuticals is raising $8,655,148.00 in new funding. Sources indicate... read more
29May

Xylyx Bio Announces Global Expansion, Adds 9 International Distributors to Meet Growing Demand

Xylyx Bio, a pioneer in physiomimetic cell culture, today announced that it is expanding globally to meet growing international demand... read more
18Aug

eSight designs technology to end blindness by 2020

With over 250 million blind people the necessity to find a solution is urgent. eSight has been working on a... read more